Lenograstim
From Infogalactic: the planetary knowledge core
| Clinical data | |
|---|---|
| Trade names | Euprotin, Granocyte, Lenobio, Neutrogin |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number | 135968-09-1  |
| ATC code | L03AA10 (WHO) |
| UNII | 6WS4C399GB  |
| (what is this?) (verify) |
|
Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator.[1][2] It is developed by Chugai Pharmaceuticals under the brand name Granocyte.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with reference errors
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Immunostimulants
- Antineoplastic and immunomodulating drug stubs
